{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:21:10Z","timestamp":1787509270789,"version":"build-2736575974"},"reference-count":45,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T00:00:00Z","timestamp":1494201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Danish council for independent research","award":["DFF-4092-00150"],"award-info":[{"award-number":["DFF-4092-00150"]}]},{"name":"The Novo Nordisk foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Increased risk of both cardiovascular disease (CVD) and bleeding has been found in patients with chronic hepatitis C (CHC) infection, and a re-balanced hemostasis has been proposed. The aim of this study was to investigate functional whole blood coagulation and platelet function in CHC infection. The prospective study included 82 patients with CHC infection (39 with advanced liver fibrosis and 43 with no or mild liver fibrosis) and 39 healthy controls. A total of 33 patients were treated for CHC infection and achieved sustained virological response (SVR). Baseline and post-treatment blood samples were collected. Hemostasis was assessed by both standard coagulation tests and functional whole blood hemostatic assays (thromboelastograhy (TEG), and platelet aggregation (Multiplate). Patients with CHC and advanced fibrosis had impaired platelet aggregation both compared to patients with no or mild fibrosis and to healthy controls. Patients with CHC and advanced fibrosis also had lower antithrombin, platelet count, and coagulation factors II-VII-X compared to healthy controls. In contrast, TEG did not differ between groups. In treated patients achieving SVR, post-treatment platelet count was higher than pre-treatment counts (p = 0.033) and ADPtest, ASPItest, and RISTOhightest all increased post treatment (all p &lt; 0.05). All Multiplate tests values, however, remained below those in the healthy controls. CHC-infected patients displayed evidence of rebalanced hemostasis with only partly hemostatic normalization in patients achieving SVR. The implications of rebalanced hemostasis and especially the impact on risk of CVD and bleeding warrants further studies.<\/jats:p>","DOI":"10.3390\/ijms18051016","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T11:45:16Z","timestamp":1494243916000},"page":"1016","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Impaired Platelet Aggregation and Rebalanced Hemostasis in Patients with Chronic Hepatitis C Virus Infection"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3083-3914","authenticated-orcid":false,"given":"Nick","family":"Nielsen","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, University Hospital of Copenhagen, Rigshospitalet, 2100 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Jespersen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University Hospital of Copenhagen, Rigshospitalet, 2100 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gaardbo","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University Hospital of Copenhagen, Rigshospitalet, 2100 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Arnbjerg","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University Hospital of Copenhagen, Rigshospitalet, 2100 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Clausen","sequence":"additional","affiliation":[{"name":"Department of Hepatology, University Hospital of Copenhagen, Rigshospitalet, 2100 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Kj\u00e6r","sequence":"additional","affiliation":[{"name":"Department of Hepatology, University Hospital of Copenhagen, Rigshospitalet, 2100 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gerstoft","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University Hospital of Copenhagen, Rigshospitalet, 2100 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibe","family":"Ballegaard","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University Hospital of Copenhagen, Rigshospitalet, 2100 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisse","family":"Ostrowski","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, University Hospital of Copenhagen, Rigshospitalet, 2100 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University Hospital of Copenhagen, Rigshospitalet, 2100 K\u00f8benhavn, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,5,8]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (WHO) (2014). Hepatitis C, WHO."},{"key":"ref_2","first-page":"47","article-title":"The natural history of hepatitis c virus (HCV) infection","volume":"3","author":"Chen","year":"2006","journal-title":"Int. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4254\/wjh.v5.i10.528","article-title":"Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations","volume":"5","author":"Zampino","year":"2013","journal-title":"World J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/hrt.2003.018937","article-title":"Evidence for association between hepatitis C virus seropositivity and coronary artery disease","volume":"90","author":"Vassalle","year":"2004","journal-title":"Heart"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1086\/599371","article-title":"Hepatitis c virus infection and the risk of coronary disease","volume":"49","author":"Butt","year":"2011","journal-title":"Clin. Infect. Diseases"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.4254\/wjh.v7.i19.2214","article-title":"Assessing cardiovascular risk in hepatitis c: An unmet need","volume":"7","author":"Ampuero","year":"2015","journal-title":"World J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7869\/tg.2012.99","article-title":"Chronic hepatitis c-associated thrombocytopenia: Aetiology and management","volume":"34","author":"Fouad","year":"2013","journal-title":"Trop. Gastroenterol."},{"key":"ref_8","first-page":"121","article-title":"Advanced liver disease: What every hepatitis c virus treater should know","volume":"19","author":"Sherman","year":"2011","journal-title":"Top. Antivir. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000103655","article-title":"Hemostatic alterations in liver disease: A review on pathophysiology, clinical consequences, and treatment","volume":"24","author":"Lisman","year":"2007","journal-title":"Dig. Surg."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Lisman, T. (2015). Hemostatic dysfunction in liver diseases. Semin. Thromb. Hemost., 445\u2013446.","DOI":"10.1055\/s-0035-1550441"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cgh.2013.02.026","article-title":"Coagulation in liver disease: A guide for the clinician","volume":"11","author":"Northup","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease: Evidence and clinical consequences","volume":"116","author":"Lisman","year":"2010","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1160\/TH03-05-0310","article-title":"Factor VIII expression in liver disease","volume":"91","author":"Hollestelle","year":"2004","journal-title":"Thromb. Haemost."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/liv.12158","article-title":"Clinical utility of viscoelastic tests of coagulation in patients with liver disease","volume":"33","author":"Mallett","year":"2013","journal-title":"Liver Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000109642","article-title":"Perioperative coagulation management and control of platelet transfusion by point-of-care platelet function analysis","volume":"34","author":"Jambor","year":"2007","journal-title":"Transf. Med. Hemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1538-7836.2006.01886.x","article-title":"Abnormal hemostasis tests and bleeding in chronic liver disease: Are they related? No","volume":"4","author":"Mannucci","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1097\/TA.0b013e31824d56ad","article-title":"Admission rapid thrombelastography predicts development of pulmonary embolism in trauma patients","volume":"72","author":"Cotton","year":"2012","journal-title":"J. Trauma Acute Care Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.surg.2009.06.054","article-title":"Rapid thrombelastography (r-teg) identifies hypercoagulability and predicts thromboembolic events in surgical patients","volume":"146","author":"Kashuk","year":"2009","journal-title":"Surgery"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1213\/ane.0b013e31818f8907","article-title":"Does thromboelastography predict postoperative thromboembolic events? A systematic review of the literature","volume":"108","author":"Dai","year":"2009","journal-title":"Anesth. Analg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1213\/01.ANE.0000155290.86795.12","article-title":"Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction","volume":"100","author":"McCrath","year":"2005","journal-title":"Anesth. Analg."},{"key":"ref_23","first-page":"1","article-title":"Utility of thromboelastography and\/or thromboelastometry in adults with sepsis: A systematic review","volume":"18","author":"Meijers","year":"2014","journal-title":"Crit. Care"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/bjs.6359","article-title":"The surgical application of point-of-care haemostasis and platelet function testing","volume":"95","author":"Dickinson","year":"2008","journal-title":"Br. J. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ejcts\/ezr001","article-title":"Hypercoagulability in patients undergoing coronary artery bypass grafting: Prevalence, patient characteristics and postoperative outcome","volume":"41","author":"Rafiq","year":"2012","journal-title":"Eur. J. Card. Thorac. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.thromres.2008.11.008","article-title":"The coagulopathy of cirrhosis assessed by thromboelastometry and its correlation with conventional coagulation parameters","volume":"124","author":"Tripodi","year":"2009","journal-title":"Thromb. Res."},{"key":"ref_27","first-page":"513","article-title":"Potential applications of thromboelastography in patients with acute and chronic liver disease","volume":"8","author":"Stravitz","year":"2012","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.jacc.2005.07.041","article-title":"Platelet reactivity in patients and recurrent events post-stenting","volume":"46","author":"Gurbel","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/VHRM.S44469","article-title":"Platelet function tests: A comparative review","volume":"11","author":"Paniccia","year":"2015","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2008.11.030","article-title":"Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis","volume":"53","author":"Sibbing","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1160\/TH09-05-0284","article-title":"Clopidogrel response status assessed with multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting","volume":"103","author":"Sibbing","year":"2010","journal-title":"Thromb. Haemost."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3109\/09537104.2014.948837","article-title":"Tailored antiplatelet therapy to improve prognosis in patients exhibiting clopidogrel low-response prior to percutaneous coronary intervention for stable angina or non-st elevation acute coronary syndrome","volume":"26","author":"Johansson","year":"2015","journal-title":"Platelets"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood-2014-05-575340","article-title":"How I treat patients with massive hemorrhage","volume":"124","author":"Johansson","year":"2014","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"European Association for Study of Liver, and Asociacion Latinoamericana para el Estudio del Higado (2015). EASL-ALEH clinical practice guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J. Hepatol., 63, 237\u2013264.","DOI":"10.1016\/j.jhep.2015.04.006"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1365-2036.2006.02889.x","article-title":"Review article: Thrombocytopenia in chronic liver disease and pharmacologic treatment options","volume":"23","author":"Giannini","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.21266","article-title":"Thrombin generation in patients with cirrhosis: The role of platelets","volume":"44","author":"Tripodi","year":"2006","journal-title":"Hepatology"},{"key":"ref_37","first-page":"614","article-title":"Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (pfa-100): Influence of hematocrit elevation","volume":"84","author":"Escolar","year":"1999","journal-title":"Haematologica"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.1840080625","article-title":"Altered platelet function in cirrhosis of the liver: Impairment of inositol lipid and arachidonic acid metabolism in response to agonists","volume":"8","author":"Laffi","year":"1988","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.thromres.2014.11.016","article-title":"No evidence for increased platelet activation in patients with hepatitis b- or c-related cirrhosis and hepatocellular carcinoma","volume":"135","author":"Alkozai","year":"2014","journal-title":"Thromb. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/apt.12273","article-title":"Long term outcome of chronic hepatitis c after sustained virological response to interferon-based therapy","volume":"37","author":"Koh","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/liv.13016","article-title":"Follow-up of patients with chronic hepatitis c and a sustained viral response","volume":"36","author":"Serfaty","year":"2016","journal-title":"Liver Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/hepr.12331","article-title":"Progressive fibrosis significantly correlates with hepatocellular carcinoma in patients with a sustained virological response","volume":"45","author":"Tachi","year":"2015","journal-title":"Hepatol. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.22694","article-title":"Clinical, virologic, histologic, and biochemical outcomes after successful hcv therapy: A 5 year follow-up of 150 patients","volume":"49","author":"George","year":"2009","journal-title":"Hepatology"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Martinez, S.M., Foucher, J., Combis, J.-M., M\u00e9tivier, S., Brunetto, M., Capron, D., Bourli\u00e8re, M., Bronowicki, J.-P., Dao, T., and Maynard-Muet, M. (2012). Longitudinal liver stiffness assessment in patients with chronic hepatitis c undergoing antiviral therapy. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047715"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2013.05.015","article-title":"Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C","volume":"59","author":"Poynard","year":"2013","journal-title":"J. Hepatol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/5\/1016\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:35:07Z","timestamp":1760207707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/5\/1016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,8]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5]]}},"alternative-id":["ijms18051016"],"URL":"https:\/\/doi.org\/10.3390\/ijms18051016","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,8]]}}}